North America Urinary Tract Infection Testing Market to Grow with a CAGR of 4.63% through 2029

The high prevalence of UTIs, coupled with technological advancements, and point-of-care testing is expected to drive the North America Urinary Tract Infection Testing Market growth in the forecast period, 2025-2029.

According to TechSci Research report, “North America Urinary Tract Infection Testing Market – Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029”, the North America Urinary Tract Infection Testing Market stood at USD 200.34 million in 2023 and is anticipated to grow with a CAGR of 4.63% through 2029. This can be attributed to the high prevalence of UTIs. One of the primary drivers of the UTI Testing Market in North America is the high prevalence of urinary tract infections in the region. UTIs can affect individuals of all ages and genders, but they are particularly common among women. With an aging population and changing lifestyles, the incidence of UTIs continues to rise. This elevated disease burden has led to a growing demand for efficient and accurate UTI diagnostic tests. Furthermore, with the increasing digitization of healthcare records, blockchain technology is gaining importance in securing patient data. Blockchain ensures the integrity and privacy of medical records, making it a crucial component in maintaining trust and compliance with data protection regulations.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "North America Urinary Tract Infection Testing Market”

The surging occurrence of urinary tract infections (UTIs) among the elderly is significantly impacting market growth in the region. A substantial portion of the aging population is vulnerable to UTIs, driving the demand for advanced UTI testing and treatment solutions. As individuals age, their susceptibility to UTIs increases due to weakened bladder and pelvic floor muscles, potentially leading to issues like urine retention or incontinence. The presence of stagnant urine in the urinary tract provides a breeding ground for bacteria, including E. coli, to multiply and cause infections. Seniors face a higher UTI risk due to factors such as compromised immune systems, catheter usage, diabetes, and kidney problems. In older women, UTIs are more prevalent due to changes in female anatomy and reduced estrogen levels post-menopause. This hormonal shift can disrupt the balance of bacteria in the vagina, elevating the risk of infection. While UTIs are less common in older men owing to male anatomy, uncircumcised men or those with enlarged prostates (benign prostatic hyperplasia or BPH) are more susceptible. UTIs associated with BPH occur when the bladder isn't fully emptied. Proper comprehension and management of these risk factors are crucial in preventing and addressing UTIs in older adults.

Additionally, the rising prevalence of catheter-associated UTIs (CAUTIs) is driving market growth for UTI testing solutions. Healthcare facilities and providers recognize the pressing need for accurate and timely UTI testing to effectively detect and manage CAUTIs. As CAUTI cases increase, there is a growing demand for advanced UTI testing equipment to identify and quantify pathogens, including drug-resistant strains. Catheter-associated UTIs (CAUTIs) are the most common healthcare-associated infections in hospitals and long-term care facilities.

Short-term catheter usage raises CAUTI risk by 3-7% each day, resulting in up to an 80% higher risk of complications during hospitalization. For long-term catheterization, the risk of complications is nearly 100%. CAUTIs are associated with increased morbidity and mortality rates and are a primary cause of secondary bacteremia. Urinary catheters bypass the body's natural immune defenses, granting microorganisms from the groin and perineum direct access to the bladder. The persistent irritation and inflammation caused by catheters within the bladder hinder normal bladder contraction and urination, making the bladder more susceptible to infection.

The growth of the market in North America is propelled by increasing research and development (R&D) efforts aimed at developing advanced UTI testing kits. Businesses and research institutions are dedicating resources to innovative technologies and advanced diagnostic sensors aimed at enhancing the early detection and precision of urinary tract infections (UTIs). These developments in UTI testing kits facilitate expedited and dependable diagnoses, resulting in enhanced patient outcomes and more efficient treatments. For instance, in May 2023, The University of Texas at Dallas unveiled a prototype diagnostic sensor capable of swiftly confirming UTIs, eliminating the necessity of waiting 24 to 48 hours for laboratory test outcomes.

The North America Urinary Tract Infection Testing Market is segmented into type, product, end-use, country distribution, and company.

Based on end-use, the reference laboratories sector claimed the largest share of revenue. These reference laboratories provide an extensive array of comprehensive testing services, including urinary tract infection (UTI) testing, to healthcare providers. These laboratories are equipped with advanced instruments and cutting-edge technologies that enable them to conduct a wide range of diagnostic tests with exceptional accuracy and efficiency. Many reference laboratories have multiple facilities and extensive geographic coverage, enabling them to cater to a vast population spanning various states and regions in North America. Additionally, reference labs have the capacity to process substantial volumes of diagnostic tests rapidly, delivering superior results at relatively lower costs, which is expected to bring about economies of scale for service providers.

Concurrently, the urogynecologists sector is poised to experience the swiftest CAGR during the forecast period. Urogynecologists primarily concentrate on women's health issues, including conditions that impact the urinary tract. Given the higher prevalence of UTIs in women, urogynecologists encounter and manage UTI cases more frequently compared to other healthcare specialists. They also conduct specific tests to identify the root causes of recurrent UTIs and prescribe appropriate treatment plans. This comprehensive approach to UTI diagnosis and management is likely to contribute to the expansion of UTI testing services within the urogynecology segment.

Based on country, the Canada is anticipated to experience the swiftest growth rate in the forthcoming years. This is primarily due to the increasing awareness about UTI management among the Canadian population and the proactive efforts of regional government authorities. For instance, in December 2019, the Canadian government introduced the Urinary Tract Infection (UTI) program to address the issue of excessive antibiotic use in long-term care homes (LTCHs) for suspected UTIs and the associated risks linked to antibiotic overuse.

Major companies operating in North America Urinary Tract Infection Testing Market are:

• QIAGEN N.V.
• Accelerate Diagnostics Inc
• Bio-Rad Laboratories Inc
• Hoffmann-La Roche Ltd
• Danaher Corp
• Siemens  Medical Solutions USA, Inc.
• Randox Laboratories Ltd
• Thermo Fisher Scientific Inc.
• bioMérieux SA
• T2 Biosystems, Inc.

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The North America Urinary Tract Infection (UTI) Testing Market is on the cusp of transformation, driven by cutting-edge technologies and a growing emphasis on patient-centered care. The adoption of point-of-care testing, the integration of AI and machine learning, the expansion of telehealth services, the rise of non-invasive testing, the era of personalized medicine, the emergence of smart healthcare devices, and the use of blockchain for data security are all poised to shape the future of UTI testing in North America”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“North America Urinary Tract Infection Testing Market By Type (Urethritis, Cystitis, Pyelonephritis), By Product (Instruments, Consumables), By End-use (General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories, Hospital Emergency Departments, Urgent Care, Others), By Country, By Competition Forecast & Opportunities, 2019-2029F”, has evaluated the future growth potential of North America Urinary Tract Infection Testing Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in North America Urinary Tract Infection Testing Market.

Contact

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +13322586602                                                     

Email: [email protected]               

Website: www.techsciresearch.com